Patent
The present invention is directed to isolated Salmonella bacteriophage, and methods of using Salmonella bacteriophage, or polynucleotides and polypeptides derived therefrom, to control the growth or contamination of food products by Salmonella . The present invention also contemplates the use of Salmonella bacteriophage, and polynucleotides and polypeptides derived therefrom, for the treatment of host infections or environmental contamination by Salmonella.
1. A substantially pure bacteriophage composition comprising at least one isolated Salmonella bacteriophage, deposited under ATCC Accession No. PTA-5280; PTA-5281; PTA-5282; PTA-5283; PTA-5284; or PTA-5285.
2. An isolated bacteriophage selected from the group consisting of SPT-1, SBA-178, SBA-1781, SIT-128, SSE-121, and SDT-15 deposited under ATCC Accession Nos. PTA-5281; PTA-5284; PTA-5282; PTA-5285; PTA-5283; or PTA-5280, respectively, and variants thereof, wherein said variants have the same phenotypic characteristics of said bacteriophage, and wherein said bacteriophage and variants thereof have the same lytic activity against Salmonella strains.
3. A composition comprising at least one of said bacteriophages of claim 2 .
4. A composition comprising at least two of said bacteriophages of claim 2 .
5. A composition comprising at least three of said bacteriophages of claim 2 .
6. A composition comprising at least four of said bacteriophages of claim 2 .
7. A composition comprising at least five of said bacteriophages of claim 2 .
8. A composition comprising at least six of said bacteriophages of claim 2 .